Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Ultra-Widefield Fluorescein Angiographic Quantitative Leakage Parameters and Clinical Outcomes in Nonproliferative Diabetic Retinopathy

Title: Ultra-Widefield Fluorescein Angiographic Quantitative Leakage Parameters and Clinical Outcomes in Nonproliferative Diabetic Retinopathy
Authors: Ehlers, Justis P.; Josic, Kristin; Aiello, Lloyd P.; Amine, Reem; Indurkar, Asmita; Martin, Alison A.; Matar, Karen; Silva, Paolo S.; Sun, Jennifer K.; Harara, Abla M; Palacios, Angela N.; Berger, Brian B.; Corak, Boris; Luong, Bianca; Jhaveri, Chirag D.; Wilson, Daniela Mariel; Jonna, Gowtham; Gunderson, Ivana; Hosein, Kimberly; Reid, Ryan M.; Chexal, Saradha; Moore, Tori; Seidu, Tina A; Gatavaski, Valerie; Ren, Yong; Stern, Bradley A.; Benvenutti, Celia E; Oude-Reimerink, Dinah S; Shaheen, Jenny; Grybas, John; Vitale-Kuhn, Julianne; Staffne, Jessica L.; Ventimiglia, Katie M.; Allis, Megan; Monk, Mary K.; Thomas, Marc E.; Massu, Nicole M.; Edwards, Paul Andrew; Troszak, Tracy A.; Irons, Amber N; Rego, Brittany; Han, Dennis P.; Dorsey, Eleanor; Nelson, Erika; Sheppard, Hannah; Beringer, Joseph R.; Kim, Judy E.; Keller, Kristy L.; Packard, Krissa L.; Altmann, Marriner L.
Source: JAMA Ophthalmology ; volume 144, issue 3, page 221 ; ISSN 2168-6165
Publisher Information: American Medical Association (AMA)
Publication Year: 2026
Description: Importance This study could facilitate the generation of automated quantitative assessments, providing clinicians and clinical trials with a continuous severity scale of retinal leakage to improve the prediction of future diabetic retinopathy (DR) worsening. Objective To examine ultra-widefield fluorescein angiography (UWF-FA) retinal leakage associated with DR progression and complications. Design, Setting, and Participants This cohort study was a post hoc analysis of the DRCR Retina Network Protocol AA clinical trial. Participants were adults with nonproliferative diabetic retinopathy (NPDR). Data was collected from February 2015 to March 2020. Analysis was performed June 2023 to April 2024. Interventions Treatment of DR or diabetic macular edema was at the investigator’s discretion. Main Outcomes and Measures Time to Diabetic Retinopathy Severity Scale (DRSS) worsening of 2 or more steps, vitreous hemorrhage (VH), and proliferative diabetic retinopathy (PDR) over 4 years. Baseline and 1-year leakage index, calculated as the area with leakage divided by the total area in the analyzable retina on UWF-FA, were evaluated as risk factors. Results Among 537 eyes (363 participants; mean [SD] age, 61 [12] years; 183 [50%] male, 180 [50%] female), the baseline leakage index (mean [SD], 3.5% [3.9%]) was associated with DRSS worsening over 4 years (hazard ratio [HR] for 1% increase, 1.09; 95% CI, 1.05-1.13; P < .001). At 1 year, 114 of 453 eyes (25%) had an absolute leakage increase 1% or greater from baseline, which was associated with a higher risk of DRSS worsening over 4 years (61% vs 33%; HR, 2.63; 95% CI, 1.90-3.64; P < .001). Baseline leakage and a 1% or greater increase at 1 year were also associated with development of VH and PDR. Conclusions and Relevance In eyes with NPDR, higher leakage at baseline and an increase from baseline to 1 year were associated with greater risk of DRSS worsening and vision-threatening complications, including VH and PDR. These findings support quantitative ...
Document Type: article in journal/newspaper
Language: English
DOI: 10.1001/jamaophthalmol.2025.5658
Availability: https://doi.org/10.1001/jamaophthalmol.2025.5658; https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2844069/jamaophthalmology_ehlers_2026_oi_250084_1772745089.40264.pdf
Accession Number: edsbas.C04FD184
Database: BASE